companies / casipharmaceuticals-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-07 json
| total_raised | 5,000,0005.0M | ○ |
|---|---|---|
| founded | 2023 | |
| hq | BEIJING, F4 | |
| industry | unknown | |
| stage | null |
CASI Pharmaceuticals is a biopharma company developing CID-103, a monoclonal antibody for organ transplant rejection and autoimmune conditions like immune thrombocytopenia. It targets transplant recipients and patients lacking adequate options on existing therapies. The anti-CD38 approach depletes plasma cells generating the harmful antibodies, addressing limitations seen with CD19 and CD20-targeted treatments.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2026-04-17 | Funding round | 5,000,0005.0M | null | ○ |
Nginx, reCAPTCHA, jQuery Migrate, parallax.js, PHP, Duda production_6455, jquery 3., friendly-challenge 0.9.8
| fact | status | src |
|---|---|---|
| Funding round, $5.0M | attributed | ○ |
| existence | sourced | WEB |
| description | self-reported | WEB |
| date | fact | change | src |
|---|---|---|---|
| 2026-10-17provenance_existence: self-reported → sourced, WEB 2026-10-17 | provenance_existence | self-reported → sourced | WEB 2026-10-17 |
| 2026-09-25latest_round: seed, $5.0M, 2026-04-17 → Funding round, $5.0M, 2026-04-17, ○ 2026-05-07 | latest_round | seed, $5.0M, 2026-04-17 → Funding round, $5.0M, 2026-04-17 | ○ 2026-05-07 |
Records begin 2026-09-24. all_changes